Category
Atenolol
CAS Number
1797116-92-7
Molecular Formula
C₁₃H₂₀N₂O₃
Molecular Weight
252.3 g/mol
Synonym

2-[4-[(2RS)-3-(Ethylamino)-2-hydroxypropoxy]phenyl]acetamide ; Atenolol Desmethyl Impurity ; Atenolol Ethylamino Analog ;C-Desmethyl Atenolol ;

Keywords
Amines
Aromatics
Impurities
Pharmaceutical Standards
Fine Chemicals
Intermediates
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Atenolol EP Impurity I (Molecular Formula: C₁₃H₂₀N₂O₃) is a pharmaceutical impurity reference material used for atenolol impurity testing, chromatographic profiling, related substance determination, degradation product evaluation, and analytical quality assessment. It is suitable for HPLC and LC-MS/MS applications, including analytical method optimization, impurity quantification, stability-indicating testing, and pharmaceutical quality control. Manasa Life Sciences is a trusted manufacturer and supplier in India of pharmaceutical impurity standards, API-related impurities, analytical reference materials, and specialty compounds, offering custom impurity synthesis, impurity identification, structural characterization, purity evaluation, forced degradation studies, and advanced analytical testing using HPLC, LC-MS/MS, NMR, FTIR, GC, QNMR, and TGA. Our products and services are supported by quality documentation such as COA and MSDS and help pharmaceutical manufacturers and analytical laboratories address applicable ICH, EMA, European Pharmacopoeia (EP), and United States Pharmacopeia (USP) requirements for impurity control, quality assurance, and regulatory compliance.